IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Net Debt Issuances and Repayments (2018 - 2026)

Updated

IRulya Therapeutics (IRLA) recorded Net Debt Issuances and Repayments of -$5.55 million in Q1 2026.

Analysis

IRulya Therapeutics (IRLA) Net Debt Issuances and Repayments (2018 - 2026) Analysis & Trends

For FY2023, IRulya Therapeutics reported Net Debt Issuances and Repayments of -$6,000.

  • Across earlier years, Net Debt Issuances and Repayments came in at -$49,000 in FY2022, -$34,000 in FY2020 and -$559,000 in FY2019.
  • The Q1 2026 figure is the highest quarterly Net Debt Issuances and Repayments in data going back to Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -4.36 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 9.98 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -682.00 Mn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -24.00 Mn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.55 Mn
Mar 31, 2023 -6,000.00
Dec 31, 2022 -18,000.00
Sep 30, 2022 -19,000.00
Jun 30, 2022 -12,000.00
Dec 31, 2020 -2,000.00
Jun 30, 2020 -3,000.00
Mar 31, 2020 -29,000.00
Mar 31, 2018 250,000.00
API Access

IRulya Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=IRLA&period=max&api_key=YOUR_API_KEY